0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-thrombotic Drugs Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-10Y18133
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti thrombotic Drugs Market Research Report 2024
BUY CHAPTERS

Global Anti-thrombotic Drugs Market Research Report 2024

Code: QYRE-Auto-10Y18133
Report
August 2024
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-thrombotic Drugs Market

The global Anti-thrombotic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Anti-thrombotic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-thrombotic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-thrombotic Drugs include Pfizer, Bayer, Johnson & Johnson, Boehringer Ingelheim Pharmaceuticals, Daiichi Sankyo, Sanofi, GlaxoSmithKline, Bristol Myers Squibb, Teva, Sandoz, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-thrombotic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-thrombotic Drugs.
The Anti-thrombotic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Anti-thrombotic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-thrombotic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-thrombotic Drugs Market Report

Report Metric Details
Report Name Anti-thrombotic Drugs Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Bayer, Johnson & Johnson, Boehringer Ingelheim Pharmaceuticals, Daiichi Sankyo, Sanofi, GlaxoSmithKline, Bristol Myers Squibb, Teva, Sandoz, Shenzhen Saibaoer Biopharmaceutical Co., Ltd., Yantai Dongcheng North Pharmaceutical Co., Ltd., Tianjin Biochemical Pharmaceutical Co., Ltd., Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd., Tianjin Hongri Pharmaceutical Co., Ltd., Henan Yonghe Pharmaceutical Co., Ltd., Beijing Shuanglu Pharmaceutical Co., Ltd., Chengdu Baiyu Pharmaceutical Co., Ltd., Shandong Xinshidai Pharmaceutical Co., Ltd., Shandong Lvyin Pharmaceutical Co., Ltd., Shijiazhuang Heping Pharmaceutical Factory, Sichuan Changzheng Pharmaceutical Co., Ltd., Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Beijing Chengji Pharmaceutical Co., Ltd., Beijing Taide Pharmaceutical Co., Ltd., Chengdu Yuandong Biopharmaceutical Co., Ltd., Chengdu Tongde Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-thrombotic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-thrombotic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Anti-thrombotic Drugs Market report?

Ans: The main players in the Anti-thrombotic Drugs Market are Pfizer, Bayer, Johnson & Johnson, Boehringer Ingelheim Pharmaceuticals, Daiichi Sankyo, Sanofi, GlaxoSmithKline, Bristol Myers Squibb, Teva, Sandoz, Shenzhen Saibaoer Biopharmaceutical Co., Ltd., Yantai Dongcheng North Pharmaceutical Co., Ltd., Tianjin Biochemical Pharmaceutical Co., Ltd., Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd., Tianjin Hongri Pharmaceutical Co., Ltd., Henan Yonghe Pharmaceutical Co., Ltd., Beijing Shuanglu Pharmaceutical Co., Ltd., Chengdu Baiyu Pharmaceutical Co., Ltd., Shandong Xinshidai Pharmaceutical Co., Ltd., Shandong Lvyin Pharmaceutical Co., Ltd., Shijiazhuang Heping Pharmaceutical Factory, Sichuan Changzheng Pharmaceutical Co., Ltd., Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Beijing Chengji Pharmaceutical Co., Ltd., Beijing Taide Pharmaceutical Co., Ltd., Chengdu Yuandong Biopharmaceutical Co., Ltd., Chengdu Tongde Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Anti-thrombotic Drugs Market report?

Ans: The Applications covered in the Anti-thrombotic Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Anti-thrombotic Drugs Market report?

Ans: The Types covered in the Anti-thrombotic Drugs Market report are Heparins, Platelet Aggregation Inhibitors, Enzymes, Other

Recommended Reports

Anticoagulant Drugs

Thrombus Devices

Thrombolytic Therapy

1 Anti-thrombotic Drugs Market Overview
1.1 Product Definition
1.2 Anti-thrombotic Drugs by Type
1.2.1 Global Anti-thrombotic Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Heparins
1.2.3 Platelet Aggregation Inhibitors
1.2.4 Enzymes
1.2.5 Other
1.3 Anti-thrombotic Drugs by Application
1.3.1 Global Anti-thrombotic Drugs Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Anti-thrombotic Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-thrombotic Drugs Revenue 2019-2030
1.4.2 Global Anti-thrombotic Drugs Sales 2019-2030
1.4.3 Global Anti-thrombotic Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-thrombotic Drugs Market Competition by Manufacturers
2.1 Global Anti-thrombotic Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-thrombotic Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-thrombotic Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Anti-thrombotic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-thrombotic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-thrombotic Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-thrombotic Drugs, Date of Enter into This Industry
2.8 Global Anti-thrombotic Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-thrombotic Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-thrombotic Drugs Players Market Share by Revenue
2.8.3 Global Anti-thrombotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-thrombotic Drugs Market Scenario by Region
3.1 Global Anti-thrombotic Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-thrombotic Drugs Sales by Region: 2019-2030
3.2.1 Global Anti-thrombotic Drugs Sales by Region: 2019-2024
3.2.2 Global Anti-thrombotic Drugs Sales by Region: 2025-2030
3.3 Global Anti-thrombotic Drugs Revenue by Region: 2019-2030
3.3.1 Global Anti-thrombotic Drugs Revenue by Region: 2019-2024
3.3.2 Global Anti-thrombotic Drugs Revenue by Region: 2025-2030
3.4 North America Anti-thrombotic Drugs Market Facts & Figures by Country
3.4.1 North America Anti-thrombotic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-thrombotic Drugs Sales by Country (2019-2030)
3.4.3 North America Anti-thrombotic Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-thrombotic Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-thrombotic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-thrombotic Drugs Sales by Country (2019-2030)
3.5.3 Europe Anti-thrombotic Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-thrombotic Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-thrombotic Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-thrombotic Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Anti-thrombotic Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-thrombotic Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-thrombotic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-thrombotic Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anti-thrombotic Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-thrombotic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-thrombotic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-thrombotic Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-thrombotic Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-thrombotic Drugs Sales by Type (2019-2030)
4.1.1 Global Anti-thrombotic Drugs Sales by Type (2019-2024)
4.1.2 Global Anti-thrombotic Drugs Sales by Type (2025-2030)
4.1.3 Global Anti-thrombotic Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anti-thrombotic Drugs Revenue by Type (2019-2030)
4.2.1 Global Anti-thrombotic Drugs Revenue by Type (2019-2024)
4.2.2 Global Anti-thrombotic Drugs Revenue by Type (2025-2030)
4.2.3 Global Anti-thrombotic Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anti-thrombotic Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-thrombotic Drugs Sales by Application (2019-2030)
5.1.1 Global Anti-thrombotic Drugs Sales by Application (2019-2024)
5.1.2 Global Anti-thrombotic Drugs Sales by Application (2025-2030)
5.1.3 Global Anti-thrombotic Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anti-thrombotic Drugs Revenue by Application (2019-2030)
5.2.1 Global Anti-thrombotic Drugs Revenue by Application (2019-2024)
5.2.2 Global Anti-thrombotic Drugs Revenue by Application (2025-2030)
5.2.3 Global Anti-thrombotic Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anti-thrombotic Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Anti-thrombotic Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Anti-thrombotic Drugs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Anti-thrombotic Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Boehringer Ingelheim Pharmaceuticals
6.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
6.4.2 Boehringer Ingelheim Pharmaceuticals Description and Business Overview
6.4.3 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolio
6.4.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
6.5 Daiichi Sankyo
6.5.1 Daiichi Sankyo Company Information
6.5.2 Daiichi Sankyo Description and Business Overview
6.5.3 Daiichi Sankyo Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Daiichi Sankyo Anti-thrombotic Drugs Product Portfolio
6.5.5 Daiichi Sankyo Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Company Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Anti-thrombotic Drugs Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 GlaxoSmithKline
6.7.1 GlaxoSmithKline Company Information
6.7.2 GlaxoSmithKline Description and Business Overview
6.7.3 GlaxoSmithKline Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 GlaxoSmithKline Anti-thrombotic Drugs Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Bristol Myers Squibb
6.8.1 Bristol Myers Squibb Company Information
6.8.2 Bristol Myers Squibb Description and Business Overview
6.8.3 Bristol Myers Squibb Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolio
6.8.5 Bristol Myers Squibb Recent Developments/Updates
6.9 Teva
6.9.1 Teva Company Information
6.9.2 Teva Description and Business Overview
6.9.3 Teva Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Anti-thrombotic Drugs Product Portfolio
6.9.5 Teva Recent Developments/Updates
6.10 Sandoz
6.10.1 Sandoz Company Information
6.10.2 Sandoz Description and Business Overview
6.10.3 Sandoz Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sandoz Anti-thrombotic Drugs Product Portfolio
6.10.5 Sandoz Recent Developments/Updates
6.11 Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
6.11.1 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Company Information
6.11.2 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.11.5 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Yantai Dongcheng North Pharmaceutical Co., Ltd.
6.12.1 Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
6.12.2 Yantai Dongcheng North Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.12.5 Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Tianjin Biochemical Pharmaceutical Co., Ltd.
6.13.1 Tianjin Biochemical Pharmaceutical Co., Ltd. Company Information
6.13.2 Tianjin Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.13.5 Tianjin Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
6.14.1 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
6.14.2 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.14.5 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Tianjin Hongri Pharmaceutical Co., Ltd.
6.15.1 Tianjin Hongri Pharmaceutical Co., Ltd. Company Information
6.15.2 Tianjin Hongri Pharmaceutical Co., Ltd. Description and Business Overview
6.15.3 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.15.5 Tianjin Hongri Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Henan Yonghe Pharmaceutical Co., Ltd.
6.16.1 Henan Yonghe Pharmaceutical Co., Ltd. Company Information
6.16.2 Henan Yonghe Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.16.5 Henan Yonghe Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Beijing Shuanglu Pharmaceutical Co., Ltd.
6.17.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
6.17.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Description and Business Overview
6.17.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.17.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.18 Chengdu Baiyu Pharmaceutical Co., Ltd.
6.18.1 Chengdu Baiyu Pharmaceutical Co., Ltd. Company Information
6.18.2 Chengdu Baiyu Pharmaceutical Co., Ltd. Description and Business Overview
6.18.3 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.18.5 Chengdu Baiyu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.19 Shandong Xinshidai Pharmaceutical Co., Ltd.
6.19.1 Shandong Xinshidai Pharmaceutical Co., Ltd. Company Information
6.19.2 Shandong Xinshidai Pharmaceutical Co., Ltd. Description and Business Overview
6.19.3 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.19.5 Shandong Xinshidai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.20 Shandong Lvyin Pharmaceutical Co., Ltd.
6.20.1 Shandong Lvyin Pharmaceutical Co., Ltd. Company Information
6.20.2 Shandong Lvyin Pharmaceutical Co., Ltd. Description and Business Overview
6.20.3 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.20.5 Shandong Lvyin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.21 Shijiazhuang Heping Pharmaceutical Factory
6.21.1 Shijiazhuang Heping Pharmaceutical Factory Company Information
6.21.2 Shijiazhuang Heping Pharmaceutical Factory Description and Business Overview
6.21.3 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolio
6.21.5 Shijiazhuang Heping Pharmaceutical Factory Recent Developments/Updates
6.22 Sichuan Changzheng Pharmaceutical Co., Ltd.
6.22.1 Sichuan Changzheng Pharmaceutical Co., Ltd. Company Information
6.22.2 Sichuan Changzheng Pharmaceutical Co., Ltd. Description and Business Overview
6.22.3 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.22.5 Sichuan Changzheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.23 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
6.23.1 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
6.23.2 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
6.23.3 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.23.5 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
6.24 Beijing Chengji Pharmaceutical Co., Ltd.
6.24.1 Beijing Chengji Pharmaceutical Co., Ltd. Company Information
6.24.2 Beijing Chengji Pharmaceutical Co., Ltd. Description and Business Overview
6.24.3 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.24.5 Beijing Chengji Pharmaceutical Co., Ltd. Recent Developments/Updates
6.25 Beijing Taide Pharmaceutical Co., Ltd.
6.25.1 Beijing Taide Pharmaceutical Co., Ltd. Company Information
6.25.2 Beijing Taide Pharmaceutical Co., Ltd. Description and Business Overview
6.25.3 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.25.5 Beijing Taide Pharmaceutical Co., Ltd. Recent Developments/Updates
6.26 Chengdu Yuandong Biopharmaceutical Co., Ltd.
6.26.1 Chengdu Yuandong Biopharmaceutical Co., Ltd. Company Information
6.26.2 Chengdu Yuandong Biopharmaceutical Co., Ltd. Description and Business Overview
6.26.3 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.26.5 Chengdu Yuandong Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.27 Chengdu Tongde Pharmaceutical Co., Ltd.
6.27.1 Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
6.27.2 Chengdu Tongde Pharmaceutical Co., Ltd. Description and Business Overview
6.27.3 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
6.27.5 Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-thrombotic Drugs Industry Chain Analysis
7.2 Anti-thrombotic Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-thrombotic Drugs Production Mode & Process
7.4 Anti-thrombotic Drugs Sales and Marketing
7.4.1 Anti-thrombotic Drugs Sales Channels
7.4.2 Anti-thrombotic Drugs Distributors
7.5 Anti-thrombotic Drugs Customers
8 Anti-thrombotic Drugs Market Dynamics
8.1 Anti-thrombotic Drugs Industry Trends
8.2 Anti-thrombotic Drugs Market Drivers
8.3 Anti-thrombotic Drugs Market Challenges
8.4 Anti-thrombotic Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Anti-thrombotic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Anti-thrombotic Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Anti-thrombotic Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Anti-thrombotic Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Anti-thrombotic Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Anti-thrombotic Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Anti-thrombotic Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Anti-thrombotic Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Anti-thrombotic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti-thrombotic Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti-thrombotic Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Anti-thrombotic Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-thrombotic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-thrombotic Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-thrombotic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Anti-thrombotic Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Anti-thrombotic Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Anti-thrombotic Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Anti-thrombotic Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Anti-thrombotic Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Anti-thrombotic Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Anti-thrombotic Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Anti-thrombotic Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Anti-thrombotic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Anti-thrombotic Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Anti-thrombotic Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Anti-thrombotic Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Anti-thrombotic Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Anti-thrombotic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Anti-thrombotic Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Anti-thrombotic Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Anti-thrombotic Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Anti-thrombotic Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Anti-thrombotic Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Anti-thrombotic Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Anti-thrombotic Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Anti-thrombotic Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Anti-thrombotic Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Anti-thrombotic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Anti-thrombotic Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Anti-thrombotic Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Anti-thrombotic Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Anti-thrombotic Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Anti-thrombotic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Anti-thrombotic Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Anti-thrombotic Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Anti-thrombotic Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Anti-thrombotic Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Anti-thrombotic Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Anti-thrombotic Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Anti-thrombotic Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Anti-thrombotic Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Anti-thrombotic Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Anti-thrombotic Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Anti-thrombotic Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Anti-thrombotic Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Anti-thrombotic Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Anti-thrombotic Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Anti-thrombotic Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Anti-thrombotic Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Anti-thrombotic Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Anti-thrombotic Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Anti-thrombotic Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Anti-thrombotic Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Anti-thrombotic Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Anti-thrombotic Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Anti-thrombotic Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Anti-thrombotic Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Pfizer Anti-thrombotic Drugs Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Bayer Anti-thrombotic Drugs Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Johnson & Johnson Anti-thrombotic Drugs Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Boehringer Ingelheim Pharmaceuticals Company Information
 Table 86. Boehringer Ingelheim Pharmaceuticals Description and Business Overview
 Table 87. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product
 Table 89. Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
 Table 90. Daiichi Sankyo Company Information
 Table 91. Daiichi Sankyo Description and Business Overview
 Table 92. Daiichi Sankyo Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Daiichi Sankyo Anti-thrombotic Drugs Product
 Table 94. Daiichi Sankyo Recent Developments/Updates
 Table 95. Sanofi Company Information
 Table 96. Sanofi Description and Business Overview
 Table 97. Sanofi Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Sanofi Anti-thrombotic Drugs Product
 Table 99. Sanofi Recent Developments/Updates
 Table 100. GlaxoSmithKline Company Information
 Table 101. GlaxoSmithKline Description and Business Overview
 Table 102. GlaxoSmithKline Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. GlaxoSmithKline Anti-thrombotic Drugs Product
 Table 104. GlaxoSmithKline Recent Developments/Updates
 Table 105. Bristol Myers Squibb Company Information
 Table 106. Bristol Myers Squibb Description and Business Overview
 Table 107. Bristol Myers Squibb Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Bristol Myers Squibb Anti-thrombotic Drugs Product
 Table 109. Bristol Myers Squibb Recent Developments/Updates
 Table 110. Teva Company Information
 Table 111. Teva Description and Business Overview
 Table 112. Teva Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Teva Anti-thrombotic Drugs Product
 Table 114. Teva Recent Developments/Updates
 Table 115. Sandoz Company Information
 Table 116. Sandoz Description and Business Overview
 Table 117. Sandoz Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Sandoz Anti-thrombotic Drugs Product
 Table 119. Sandoz Recent Developments/Updates
 Table 120. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Company Information
 Table 121. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 122. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 124. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 125. Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
 Table 126. Yantai Dongcheng North Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 129. Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Tianjin Biochemical Pharmaceutical Co., Ltd. Company Information
 Table 131. Tianjin Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
 Table 132. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 134. Tianjin Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 135. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
 Table 136. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
 Table 137. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 139. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 140. Tianjin Hongri Pharmaceutical Co., Ltd. Company Information
 Table 141. Tianjin Hongri Pharmaceutical Co., Ltd. Description and Business Overview
 Table 142. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 144. Tianjin Hongri Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 145. Henan Yonghe Pharmaceutical Co., Ltd. Company Information
 Table 146. Henan Yonghe Pharmaceutical Co., Ltd. Description and Business Overview
 Table 147. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 149. Henan Yonghe Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 150. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
 Table 151. Beijing Shuanglu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 152. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 154. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 155. Chengdu Baiyu Pharmaceutical Co., Ltd. Company Information
 Table 156. Chengdu Baiyu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 157. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 159. Chengdu Baiyu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 160. Shandong Xinshidai Pharmaceutical Co., Ltd. Company Information
 Table 161. Shandong Xinshidai Pharmaceutical Co., Ltd. Description and Business Overview
 Table 162. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 164. Shandong Xinshidai Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 165. Shandong Lvyin Pharmaceutical Co., Ltd. Company Information
 Table 166. Shandong Lvyin Pharmaceutical Co., Ltd. Description and Business Overview
 Table 167. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 169. Shandong Lvyin Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 170. Shijiazhuang Heping Pharmaceutical Factory Company Information
 Table 171. Shijiazhuang Heping Pharmaceutical Factory Description and Business Overview
 Table 172. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 173. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product
 Table 174. Shijiazhuang Heping Pharmaceutical Factory Recent Developments/Updates
 Table 175. Sichuan Changzheng Pharmaceutical Co., Ltd. Company Information
 Table 176. Sichuan Changzheng Pharmaceutical Co., Ltd. Description and Business Overview
 Table 177. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 178. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 179. Sichuan Changzheng Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 180. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
 Table 181. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
 Table 182. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 183. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 184. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 185. Beijing Chengji Pharmaceutical Co., Ltd. Company Information
 Table 186. Beijing Chengji Pharmaceutical Co., Ltd. Description and Business Overview
 Table 187. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 188. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 189. Beijing Chengji Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 190. Beijing Taide Pharmaceutical Co., Ltd. Company Information
 Table 191. Beijing Taide Pharmaceutical Co., Ltd. Description and Business Overview
 Table 192. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 193. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 194. Beijing Taide Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 195. Chengdu Yuandong Biopharmaceutical Co., Ltd. Company Information
 Table 196. Chengdu Yuandong Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 197. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 198. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 199. Chengdu Yuandong Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 200. Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
 Table 201. Chengdu Tongde Pharmaceutical Co., Ltd. Description and Business Overview
 Table 202. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 203. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product
 Table 204. Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 205. Key Raw Materials Lists
 Table 206. Raw Materials Key Suppliers Lists
 Table 207. Anti-thrombotic Drugs Distributors List
 Table 208. Anti-thrombotic Drugs Customers List
 Table 209. Anti-thrombotic Drugs Market Trends
 Table 210. Anti-thrombotic Drugs Market Drivers
 Table 211. Anti-thrombotic Drugs Market Challenges
 Table 212. Anti-thrombotic Drugs Market Restraints
 Table 213. Research Programs/Design for This Report
 Table 214. Key Data Information from Secondary Sources
 Table 215. Key Data Information from Primary Sources
 Table 216. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-thrombotic Drugs
 Figure 2. Global Anti-thrombotic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Anti-thrombotic Drugs Market Share by Type: 2023 & 2030
 Figure 4. Heparins Product Picture
 Figure 5. Platelet Aggregation Inhibitors Product Picture
 Figure 6. Enzymes Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Anti-thrombotic Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Anti-thrombotic Drugs Market Share by Application: 2023 & 2030
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Other
 Figure 13. Global Anti-thrombotic Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Anti-thrombotic Drugs Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Anti-thrombotic Drugs Sales (2019-2030) & (K Units)
 Figure 16. Global Anti-thrombotic Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 17. Anti-thrombotic Drugs Report Years Considered
 Figure 18. Anti-thrombotic Drugs Sales Share by Manufacturers in 2023
 Figure 19. Global Anti-thrombotic Drugs Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Anti-thrombotic Drugs Players: Market Share by Revenue in Anti-thrombotic Drugs in 2023
 Figure 21. Anti-thrombotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Anti-thrombotic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Anti-thrombotic Drugs Sales Market Share by Country (2019-2030)
 Figure 24. North America Anti-thrombotic Drugs Revenue Market Share by Country (2019-2030)
 Figure 25. United States Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Anti-thrombotic Drugs Sales Market Share by Country (2019-2030)
 Figure 28. Europe Anti-thrombotic Drugs Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Anti-thrombotic Drugs Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Anti-thrombotic Drugs Revenue Market Share by Region (2019-2030)
 Figure 36. China Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Anti-thrombotic Drugs Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Anti-thrombotic Drugs Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Anti-thrombotic Drugs Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Anti-thrombotic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Anti-thrombotic Drugs by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Anti-thrombotic Drugs by Type (2019-2030)
 Figure 55. Global Anti-thrombotic Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Anti-thrombotic Drugs by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Anti-thrombotic Drugs by Application (2019-2030)
 Figure 58. Global Anti-thrombotic Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 59. Anti-thrombotic Drugs Value Chain
 Figure 60. Anti-thrombotic Drugs Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India